Medical/Pharmaceuticals

Advanced Aesthetic Technologies, Inc. is pleased to announce the approval of Algeness® VL agarose facial injection filler for marketing in China

AAT announces additional significant updates RADNOR, Pa., Jan. 29, 2025 /PRNewswire/ -- Advanced Aesthetic Technologies, Inc. ("AAT") announced today that their partner inChina has obtained approval to market their unique dermal filler Algeness® VL agarose facial injection filler, a 2.5% agarose...

2025-01-29 14:00 3825

Spectra Medical, XL Precision Technologies Announce Rebrand as Elevaris Medical Devices

Legacy of Trust and Expertise Ushers in New Era of Precision Medical Device Development and Manufacturing Capabilities BOSTON, Jan. 28, 2025 /PRNewswire/ -- Spectra Medical Devices (Spectra) and XL Precision Technologies (XLPT) announced today their newly combined brand presence as Elevaris Medi...

2025-01-28 23:15 4116

Getinge Year End Report 2024: Strong order intake and increased sales contributed to sharp improvement in margins

GOTHENBURG, Sweden, Jan. 28, 2025 /PRNewswire/ -- "In 2024, Getinge had record sales and we finished off the year with a strong quarter. Both order intake and net sales increased significantly, also organically, with positive performance in all regions", says Mattias Perjos, CEO of Getinge. Grow...

2025-01-28 22:39 3681

SOPHiA GENETICS Launches Comprehensive MRD Tracking Capabilities

The cutting-edge OncoPortal™ Mutation Tracker add-on module enables precision monitoring of evolving genomic cancer drivers BOSTON, MA and ROLLE, Switzerland, Jan. 28, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-dr...

2025-01-28 22:07 3490

Athinoula A. Martinos Center for Biomedical Imaging at Massachusetts General Hospital Chooses a United Imaging Next Generation PET/CT to Revolutionize the Study of Systems Physiology

HOUSTON, Jan. 28, 2025 /PRNewswire/ -- As pioneers in biomedical imaging and neuroscience, the researchers at the Athinoula A. Martinos Center for Biomedical Imaging atMassachusetts General Hospital (MGH), a founding member of the Mass General Brigham healthcare system, have long appreciated the ...

2025-01-28 22:00 3624

Corti Launches Specialized Healthcare AI Infrastructure, Challenging Industry Misuse of General-Purpose Models

New purpose-built models, inspired by medical residency, tackle rising distractions and "pilot paralysis" from healthcare's increasing reliance on general-purpose AI NEW YORK, Jan. 28, 2025 /PRNewswire/ -- A new report from Corti and YouGov has revealed that a third of U.S. healthcare profession...

2025-01-28 14:00 3242

Telix Completes Acquisition of RLS (USA) Inc.

MELBOURNE, Australia and INDIANAPOLIS, Jan. 28, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces it has completed the acquisition of RLS (USA) Inc. (RLS; RLS Radiopharmacies), America's only Joint Commission-accredited radiopharmacy n...

2025-01-28 05:40 7754

ThinkCyte expands product portfolio to drive innovation in drug discovery and disease research.

TOKYO, Jan. 28, 2025 /PRNewswire/ -- ThinkCyte, a biotechnology company pioneering novel artificial intelligence (AI)-based cell analysis and sorting instruments, announced today that it will begin the pre-commercial launch of its new cell analysis platform, VisionCyte™. The announcement coincide...

2025-01-28 00:00 3814

Advanced Instruments Releases the OsmoPRO® MAX Automated Osmometer to Enhance Clinical Lab Productivity

The OsmoPRO® MAX Automated Osmometer delivers the automation and data management capabilities required by modern clinical labs. NORWOOD, Mass., Jan. 27, 2025 /PRNewswire/ -- Advanced Instruments, the leading supplier in osmolality testing, announces the newest update to its clinical line of free...

2025-01-27 22:28 3461

Seeking Investors: First-in-Class Immunotherapeutics for Cancer

ATLANTA, Jan. 27, 2025 /PRNewswire/ -- Cambium Oncology is pleased to share that their lead drug candidate, ANT308, recently demonstrated outstanding single-agent efficacy and safety in preclinical studies. The drug is mutation-agnostic, and the company observes no toxicity-limiting dosages. In ...

2025-01-27 19:58 3444

CStone Partners with SteinCares to Market Sugemalimab in Latin America

* CStone will receive upfront, regulatory and commercial milestone payments, and book revenue from SteinCares through the supply of sugemalimab in 10 Latin American (LATAM) countries. * This marks CStone's third major global commercialization partnership for sugemalimab, with additional deals...

2025-01-27 12:30 3098

Arab Health 2025|Yuwell Medical Announces Strategic Investment and Partnership with Inogen in Respiratory Health

DUBAI, UAE, Jan. 27, 2025 /PRNewswire/ -- On the eve of the Arab Health Exhibition, Yuwell Medical held its 2025 Global Core Partner Conference in Dubai , and announced astrategic investment and partnership with Inogen, a leading U.S. company in respiratory health, highlighting our joint commitmen...

2025-01-27 11:25 4895

Akeso's Gumokimab Monoclonal Antibody (IL-17) New Drug Application for the Treatment of Moderate to Severe Psoriasis Accepted by NMPA

HONG KONG, Jan. 26, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the New Drug Application (NDA) of its internally-developed IL-17-targeting monoclonal antibody gumokimab (AK111) has been accepted by the Center for Drug Evaluation (CDE) of the N...

2025-01-27 09:53 2914

CARiNG Pharmacy Celebrates Consecutive Gold Triumph at the 2024 Putra Aria Brand Awards

KUALA LUMPUR, Malaysia, Jan. 27, 2025 /PRNewswire/ -- CARiNG Pharmacy is thrilled to announce its back-to-back victory in securing the Gold award in the retail category at the 2024 Putra Aria Brand Awards. This recognition highlights the brand's unwavering commitment to excellence in the retail ...

2025-01-27 08:33 3663

Alpro Pharmacy and OMRON Healthcare Unite to Combat Fake BP Monitors

Free Blood Pressure Monitor Accuracy Check Nationwide KUALA LUMPUR, Malaysia, Jan. 27, 2025 /PRNewswire/ -- Hypertension, or high blood pressure, affects 3 in 10 Malaysians, making it a prevalent health concern in the country (National Health and Morbidity Survey, 2019). Of the 3, only 2 are awa...

2025-01-27 08:00 4768

FDA Clears World's First Mobile App for Contactless Pulse Rate Measurement

* PanopticAI's tech turns smartphones and tablets into medical-grade vital sign monitors. * This is a major milestone in the Hong Kong-based startup's mission to ensure accessible, scalable healthcare. * The AI-based technology's diverse use cases include telehealth, remote patient monitori...

2025-01-26 10:00 7663

X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor - licenced to Norgine for commercialisation in Europe.

LONDON, Jan. 25, 2025 /PRNewswire/ -- Following the licensing agreement with X4 Pharmaceuticals, Norgine is pleased to see the announcement from X4 today that their Marketing Authorization Application (MAA) for mavorixafor for the treatment of WHIM syndrome (warts, hypogammaglobulinemia, infectio...

2025-01-25 02:00 6264

Clarity receives U.S. FDA Fast Track Designation for Cu-64 SAR-bisPSMA in biochemical recurrence of prostate cancer

SYDNEY, Jan. 24, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, is pleased to announce that the U...

2025-01-24 22:02 4810

Nuevocor Welcomes Andreas Wallnöfer as Chairman of the Board of Directors

SINGAPORE and PHILADELPHIA, Jan. 24, 2025 /PRNewswire/ -- Nuevocor , an IND-stage biotechnology company dedicated to developing functional cures to treat cardiomyopathies with aberrant mechanobiology, today announces the appointment ofDr. Andreas Wallnöfer as Chairman ...

2025-01-24 22:00 5064

Winter Davos 2025: Yidu Tech Accelerates Global Expansion of AI-Powered Healthcare Solutions

DAVOS, Switzerland, Jan. 24, 2025 /PRNewswire/ -- From January 20 to 24, the World Economic Forum Annual Meeting 2025, also known asWinter Davos, gathered global leaders inDavos, Switzerland. Representing China's AI-powered healthcare sector, Ms. Gong Rujing(Yingying), Founder and Chairwoman of Y...

2025-01-24 21:47 5551
1 ... 127128129130131132133 ... 646

Week's Top Stories